Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review

[1] Belkaid Y(2014)Role of the microbiota in immunity and inflammation Cell 157 121-141

[2] Hand TW(2015)Dysbiosis of the gut microbiota in disease Microb Ecol Health Dis 26 26191-209

[3] Carding S(2015)The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems Ann Gastroenterol 28 203-382

[4] Verbeke K(2017)The gut microbiome in human neurological disease: a review Ann Neurol 81 369-86e16

[5] Vipond DT(2020)The multiple sclerosis gut microbiota: a systematic review Mult Scler Relat Disord 37 3467-e1063

[6] Corfe BM(2022)Therapeutic advances in multiple sclerosis Front Neurol 185 e1050-503

[7] Owen LJ(2022)Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course Cell 98 3728-1211

[8] Carabotti M(2022)Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome Neurology 12 495-2269

[9] Scirocco A(2022)B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients Sci Rep 36 1195-734

[10] Maselli MA(2021)The influence of interferon beta-1b on gut microbiota composition in patients with multiple sclerosis Neurologia (Engl Ed) 89 2252-627

[1] Belkaid Y(2014)Role of the microbiota in immunity and inflammation Cell 157 121-141

[2] Hand TW(2015)Dysbiosis of the gut microbiota in disease Microb Ecol Health Dis 26 26191-209

[3] Carding S(2015)The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems Ann Gastroenterol 28 203-382

[4] Verbeke K(2017)The gut microbiome in human neurological disease: a review Ann Neurol 81 369-86e16

[5] Vipond DT(2020)The multiple sclerosis gut microbiota: a systematic review Mult Scler Relat Disord 37 3467-e1063

[6] Corfe BM(2022)Therapeutic advances in multiple sclerosis Front Neurol 185 e1050-503

[7] Owen LJ(2022)Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course Cell 98 3728-1211

[8] Carabotti M(2022)Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome Neurology 12 495-2269

[9] Scirocco A(2022)B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients Sci Rep 36 1195-734

[10] Maselli MA(2021)The influence of interferon beta-1b on gut microbiota composition in patients with multiple sclerosis Neurologia (Engl Ed) 89 2252-627